Mulligan Mobilization in Lateral Elbow Tendinopathy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorIstanbul Kent University
About this trial
The aim of this randomized placebo-controlled trial is to investigate the effects of Mulligan Mobilization with Movement (MWM) combined with an exercise program in individuals with lateral elbow tendinopathy. The study will compare MWM plus exercise with sham MWM plus exercise and exercise alone.
A total of 45 participants will be randomly allocated to one of the three intervention groups. The study will evaluate whether adding MWM to exercise provides greater improvements in pain, physical function, muscle performance, proprioception, and biomechanical outcomes than sham mobilization or exercise alone. Assessments will be performed at baseline, 2 days after completion of the 4-week intervention, and 24 weeks after completion of the intervention.
Eligibility criteria
Qualifiers
Inclusion Criteria
Age between 18 and 60 years
Presence of unilateral lateral elbow pain and tenderness for at least 3 months
Local tenderness over the lateral epicondyle
Disqualifiers
History of surgery around the elbow
History of elbow dislocation, fracture, or extensor tendon rupture
History of fracture of the humerus, ulna, or radius within the past year
Receipt of any treatment for LET within the past 6 months (e.g., physiotherapy, exercise, manual therapy, dry needling, orthosis)
Trial design
Treatments tested in this trial
- Mobilization with Movement (MWM)
- Sham Mobilization with Movement (Sham MWM)
- Exercise
Treatment groups
45 Participants
are divided into 3 treatment groupsSponsors and collaborators
Istanbul Kent University
Lead sponsor
Istanbul University - Cerrahpasa
Collaborator
Source ClinicalTrials.gov